Since taking over as CEO of Thuasne in 1991, Elizabeth Ducottet has never stopped developing Thuasne’s international presence. That strategy has borne fruit, with 15 subsidiaries in Europe, the United States and Asia, making it one of the leading players in the global market for medical devices. Here, she looks back at the past challenges with this strategy and the prospects ahead for Thuasne.